Balchem Corp
BCPC156.300USD
-2.420-1.52%
Cierre 12/19, 16:00（ET）Cotizaciones retrasadas 15 min
5.06BCap. mercado
33.90P/E TTM
Más Datos de Balchem Corp Compañía
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Información de Balchem Corp
Símbolo de cotizaciónBCPC
Nombre de la empresaBalchem Corp
Fecha de salida a bolsaJun 03, 1986
Director ejecutivoHarris (Theodore L)
Número de empleados1361
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 03
Dirección- -
Ciudad- -
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
País- -
Código postal- -
Teléfono- -
Sitio Web- -
Símbolo de cotizaciónBCPC
Fecha de salida a bolsaJun 03, 1986
Director ejecutivoHarris (Theodore L)
Ejecutivos de Balchem Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
61.58K
-0.77%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
5.94K
-25.19%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
1.55K
-23.80%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
410.00
-78.03%
Mr. Matthew D. (Matt) Wineinger
Mr. Matthew D. (Matt) Wineinger
Lead Independent Director
Lead Independent Director
--
--
Mr. C. Martin Bengtsson
Mr. C. Martin Bengtsson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Monica Vicente
Ms. Monica Vicente
Independent Director
Independent Director
--
-100.00%
Mr. Olivier Rigaud
Mr. Olivier Rigaud
Independent Director
Independent Director
--
-100.00%
Mr. Daniel E. Knutson, CPA
Mr. Daniel E. Knutson, CPA
Independent Director
Independent Director
--
--
Mr. Martin L. Reid
Mr. Martin L. Reid
Senior Vice President and Chief Supply Chain Officer
Senior Vice President and Chief Supply Chain Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Theodore L. (Ted) Harris
Mr. Theodore L. (Ted) Harris
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
61.58K
-0.77%
Mr. David B. (Dave) Fischer
Mr. David B. (Dave) Fischer
Independent Director
Independent Director
5.94K
-25.19%
Ms. Hatsuki Miyata
Ms. Hatsuki Miyata
Executive Vice President, Chief Legal Officer and Secretary
Executive Vice President, Chief Legal Officer and Secretary
1.55K
-23.80%
Mr. Frederic Boned
Mr. Frederic Boned
Senior Vice President, General Manager - Human Nutrition and Health
Senior Vice President, General Manager - Human Nutrition and Health
410.00
-78.03%
Mr. Matthew D. (Matt) Wineinger
Mr. Matthew D. (Matt) Wineinger
Lead Independent Director
Lead Independent Director
--
--
Mr. C. Martin Bengtsson
Mr. C. Martin Bengtsson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Product Sales Revenue
255.04M
99.83%
Royalty
426.00K
0.17%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
186.71M
73.08%
Foreign Countries
68.76M
26.92%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Product Sales Revenue
255.04M
99.83%
Royalty
426.00K
0.17%
Estadísticas de accionistas
Actualizado: mié., 8 de oct
Actualizado: mié., 8 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.43%
The Vanguard Group, Inc.
12.00%
Conestoga Capital Advisors, LLC
3.93%
State Street Investment Management (US)
3.71%
Wasatch Global Investors Inc
3.34%
Otro
63.60%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.43%
The Vanguard Group, Inc.
12.00%
Conestoga Capital Advisors, LLC
3.93%
State Street Investment Management (US)
3.71%
Wasatch Global Investors Inc
3.34%
Otro
63.60%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
51.15%
Investment Advisor/Hedge Fund
28.69%
Hedge Fund
6.00%
Pension Fund
2.43%
Research Firm
1.95%
Sovereign Wealth Fund
1.59%
Bank and Trust
1.04%
Individual Investor
0.54%
Family Office
0.06%
Otro
6.56%
Participación institucional
Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
692
30.08M
92.73%
+17.89K
2025Q3
707
30.06M
92.66%
+267.74K
2025Q2
685
29.78M
92.71%
+58.29K
2025Q1
661
29.74M
93.11%
-556.18K
2024Q4
638
29.76M
94.56%
+6.32K
2024Q3
611
29.83M
94.33%
+196.23K
2024Q2
600
29.66M
94.99%
-187.86K
2024Q1
588
29.84M
94.20%
-559.06K
2023Q4
578
29.57M
93.53%
+265.95K
2023Q3
565
29.33M
93.21%
-102.61K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
4.44M
13.67%
-111.30K
-2.45%
Jun 30, 2025
The Vanguard Group, Inc.
3.89M
11.99%
+47.60K
+1.24%
Jun 30, 2025
Conestoga Capital Advisors, LLC
1.15M
3.54%
-19.03K
-1.63%
Jun 30, 2025
State Street Investment Management (US)
1.23M
3.78%
-1.53K
-0.12%
Jun 30, 2025
Wasatch Global Investors Inc
960.09K
2.96%
-108.92K
-10.19%
Jun 30, 2025
Geode Capital Management, L.L.C.
980.97K
3.02%
+14.33K
+1.48%
Jun 30, 2025
Geneva Capital Management LLC
895.53K
2.76%
+64.72K
+7.79%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
575.40K
1.77%
-18.35K
-3.09%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
469.08K
1.45%
+38.60K
+8.97%
Jun 30, 2025
JP Morgan Asset Management
389.05K
1.2%
-7.19K
-1.82%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Invesco S&P SmallCap Materials ETF
6.89%
Invesco S&P SmallCap Quality ETF
1.2%
First Trust Horizon Managed Vol Small/Mid ETF
1.05%
ProShares Russell 2000 Dividend Growers ETF
0.91%
Invesco S&P SmallCap Low Volatility ETF
0.87%
State Street SPDR S&P 600 Small Cap Growth ETF
0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.64%
iShares S&P Small-Cap 600 Growth ETF
0.63%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.57%
Parametric Equity Premium Income ETF
0.56%
Ver más
Invesco S&P SmallCap Materials ETF
Proporción6.89%
Invesco S&P SmallCap Quality ETF
Proporción1.2%
First Trust Horizon Managed Vol Small/Mid ETF
Proporción1.05%
ProShares Russell 2000 Dividend Growers ETF
Proporción0.91%
Invesco S&P SmallCap Low Volatility ETF
Proporción0.87%
State Street SPDR S&P 600 Small Cap Growth ETF
Proporción0.68%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proporción0.64%
iShares S&P Small-Cap 600 Growth ETF
Proporción0.63%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proporción0.57%
Parametric Equity Premium Income ETF
Proporción0.56%
Dividendos
Un total de
104.59M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Dec 10, 2025
BCPC.NB Final Cash Dividend of gross USD 0.96 paid on Jan 20, 2026 going ex on Dec 23, 2025
Dec 23, 2025
Jan 20, 2026
Dec 23, 2025
Dec 10, 2024
BCPC.NB Final Cash Dividend of gross USD 0.87 paid on Jan 17, 2025 going ex on Dec 26, 2024
Dec 26, 2024
Jan 17, 2025
Dec 26, 2024
Dec 05, 2023
BCPC.NB Final Cash Dividend of gross USD 0.79 paid on Jan 19, 2024 going ex on Dec 26, 2023
Dec 27, 2023
Jan 19, 2024
Dec 26, 2023
Dec 06, 2022
BCPC.NB Final Cash Dividend of gross USD 0.71 paid on Jan 20, 2023 going ex on Dec 23, 2022
Dec 27, 2022
Jan 20, 2023
Dec 23, 2022
Dec 16, 2021
BCPC.NB Final Cash Dividend of gross USD 0.64 paid on Jan 21, 2022 going ex on Dec 27, 2021
Dec 28, 2021
Jan 21, 2022
Dec 27, 2021
Dec 17, 2020
BCPC.NB Final Cash Dividend of gross USD 0.58 paid on Jan 22, 2021 going ex on Dec 24, 2020
Dec 28, 2020
Jan 22, 2021
Dec 24, 2020
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Balchem Corp?
Los cinco principales accionistas de Balchem Corp son:
BlackRock Institutional Trust Company, N.A. posee 4.44M acciones, lo que representa el 13.67% del total de acciones.
The Vanguard Group, Inc. posee 3.89M acciones, lo que representa el 11.99% del total de acciones.
Conestoga Capital Advisors, LLC posee 1.15M acciones, lo que representa el 3.54% del total de acciones.
State Street Investment Management (US) posee 1.23M acciones, lo que representa el 3.78% del total de acciones.
Wasatch Global Investors Inc posee 960.09K acciones, lo que representa el 2.96% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 4.44M acciones, lo que representa el 13.67% del total de acciones.
The Vanguard Group, Inc. posee 3.89M acciones, lo que representa el 11.99% del total de acciones.
Conestoga Capital Advisors, LLC posee 1.15M acciones, lo que representa el 3.54% del total de acciones.
State Street Investment Management (US) posee 1.23M acciones, lo que representa el 3.78% del total de acciones.
Wasatch Global Investors Inc posee 960.09K acciones, lo que representa el 2.96% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Balchem Corp?
Los tres principales tipos de accionista de Balchem Corp son:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Conestoga Capital Advisors, LLC
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Conestoga Capital Advisors, LLC
¿Cuántas instituciones poseen acciones de Balchem Corp (BCPC)?
A fecha de 2025Q4, 692 instituciones poseen acciones de Balchem Corp, con un valor de mercado combinado de aproximadamente 30.08M, lo que representa el 92.73% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en 0.07%.
¿Cuál es la mayor fuente de ganancias de Balchem Corp?
El FY2025Q2, el segmento empresarial Product Sales Revenue generó la ganancia más alta para Balchem Corp, ascendiendo a 255.04M y representando el 99.83% de la ganancia total.
